![Magnus Edlund](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Magnus Edlund
Directeur/Membre du Conseil chez
Immedica Pharma AB
Profil
Magnus Edlund is currently the Director at Immedica Pharma AB since 2018 and a Partner at Impilo AB since 2017.
Previously, he worked as a Director at Altor Equity Partners AB from 2009 to 2017.
Postes actifs de Magnus Edlund
| Sociétés | Poste | Début |
|---|---|---|
Impilo AB
 Impilo AB Investment ManagersFinance Impilo invests in both private and public companies located in Sweden with an enterprise value of EUR 50 - 200 million. The firm focuses on the healthcare sector or companies working in health-related industries. It provides financing for buyout transactions. It acquires minority or majority interest. It also makes ESG investments. | Private Equity Investor | 01/09/2017 |
Immedica Pharma AB
 Immedica Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops medicines for rare, genetic and metabolic diseases, hematology & oncology and specialty care | Directeur/Membre du Conseil | 01/05/2018 |
Anciens postes connus de Magnus Edlund
| Sociétés | Poste | Fin |
|---|---|---|
Altor Equity Partners AB
 Altor Equity Partners AB Investment ManagersFinance Altor Equity Partners invests in private and public middle market companies located in Sweden. The firm focuses on business services, consumer, financial services, industrial and tech sectors. It provides financing for buyout transactions and also takes minority interest. | Directeur/Membre du Conseil | 31/08/2017 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
26
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Altor Equity Partners AB
Altor Equity Partners AB Investment ManagersFinance Altor Equity Partners invests in private and public middle market companies located in Sweden. The firm focuses on business services, consumer, financial services, industrial and tech sectors. It provides financing for buyout transactions and also takes minority interest. | Finance |
Immedica Pharma AB
Immedica Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops medicines for rare, genetic and metabolic diseases, hematology & oncology and specialty care | Health Technology |
Impilo AB
Impilo AB Investment ManagersFinance Impilo invests in both private and public companies located in Sweden with an enterprise value of EUR 50 - 200 million. The firm focuses on the healthcare sector or companies working in health-related industries. It provides financing for buyout transactions. It acquires minority or majority interest. It also makes ESG investments. | Finance |
